Article info

Download PDFPDF

Interleukin-4 as an emerging therapeutic target for IgG4-related disease
Free

Authors

  1. Correspondence to Dr Yuko Kaneko, Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, Japan; ykaneko.z6{at}keio.jp
View Full Text

Citation

Akiyama M, Kaneko Y, Takeuchi T
Interleukin-4 as an emerging therapeutic target for IgG4-related disease

Publication history

  • Received January 7, 2020
  • Accepted January 10, 2020
  • First published January 20, 2020.
Online issue publication 
January 12, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.